TrialAntimicrobial agents and chemotherapy2020

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of MHAA4549A, a Monoclonal Antibody, plus Oseltamivir in Patients Hospitalized with Severe Influenza A Virus Infection.

Jeremy J Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.